Sorilux® (calcipotriene) – Expanded indication
November 5, 2019 - The FDA approved Mayne Pharma’s Sorilux (calcipotriene) foam, for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older.
Download PDF
